Management of Barrett's Esophagus With and Without Dysplasia

References

• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991;265:1287–9.
   Google Scholar
• Buttar NS, Falk GW. Pathogenesis of gastroesophageal reflux and Barrett esophagus. Mayo Clin Proc 2001;76:226–34.
   PubMedGoogle Scholar
• DeMeester SR, Peters JH, DeMeester TR. Barrett’s esophagus. Curr Probl Surg 2001;38:558–640.
   Google Scholar
• Fitzgeral RC, Omary MB, Triadafilopoulos G. Altered sodiumhydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett’s esophagus. Am J Physiol 1998; 38:G47–55.
   Google Scholar
• Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett’s esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 1996;98:212–8.
   Google Scholar
• Fitzgerald RC, Triadafilopoulos G. Recent developments in the molecular characterization of Barrett’s esophagus. Dig Dis Sci 1998;16:63–80.
   Google Scholar
• Gillen P, Keeling P, Byrne P, et al. Implication of duodenogastric reflux in the pathogenesis of Barrett’s esophagus. Br J Surg 1998;75:540–3.
   Google Scholar
• Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965–73.
   PubMed Web of Science ®Google Scholar
• Kandil HM, Tanner G, Smalley W, Halter S, Radhika A, Dubois RN. Cyclooxygenase-2 expression in Barrett’s esophagus. Dig Dis Sci 2001;46:758–9.
   Google Scholar
• Kaur BS, Quatu-Lascar R, Omary MB, Triadafilopoulos G. Bile salts induce or blunt cell proliferation in Barrett’s esophagus in an acid-dependent fashion. Am Physiol (Gastrointest Liver Physiol) 2000;278:G1000–9.
   Google Scholar
• Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001;76:438–46.
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergstrom R, Lingren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
   PubMed Web of Science ®Google Scholar
• Levine D, Haggitt R, Blount P, Rabinovitch P, Rusch V, Reid B. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 1993;105:40–50.
   PubMed Web of Science ®Google Scholar
• Locke GR, Talley N, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux. A population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448–56.
   Google Scholar
• Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE. Cyclooxygenase-2 expression in the Barrett’s metaplasia-dysplasia-adenocarnoma sequence. Am J Gastroenterol 2001;96: 990–6.
   Google Scholar
• Neumann C, Iqbal T, Cooper B. Long-term continuous omeprazole treatment of patients with Barrett’s esophagus. Aliment Pharmacol Ther 1995;9:451–4.
   Google Scholar
• Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, et al. Endoscopic regression of Barrett’s oesophagus during omeprazole therapy: a randomized double blind study. Gut 1999;45:489–94.
   Google Scholar
• Quatu-Lascar R, Fitzgerald RV, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology 1999;117: 327–35.
   Google Scholar
• Richter JE. Importance of bile reflux in Barrett’s esophagus. Dig Dis:2000–200118:208–16.
   Google Scholar
• Sampliner RE, and the practice parameters committee of the American College of Gastroenterology., Practice guidelines on the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 1998;93:1028–32.
   Google Scholar
• Sarr M, Hamilton S, Marrone G, Cameron J. Barrett’s esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985;149:187–93.
   PubMed Web of Science ®Google Scholar
• Souza RF, Morales CP, Spechler SJ. A conceptual approach to understanding the molecular mechanisms of cancer development in Barrett’s esophagus. Aliment Pharmacol Ther 2001;15:1087–100.
   Google Scholar
• Souza RF, Shewmake K, Terada LS, Spechler SJ. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett’s esophagus. Gastroenterology 2002;122:299–307.
   PubMedGoogle Scholar
• Spechler S, Goyal R. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614–21.
   PubMed Web of Science ®Google Scholar
• Spechler SJ. Barrett’s esophagus. N Engl J Med 2002;346:836–42.
   PubMed Web of Science ®Google Scholar
• Shirvani VN, Quatu-Lascar R, Kaur BS, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett’s esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487–96.
   PubMed Web of Science ®Google Scholar
• Triadafilopoulos G. Acid and bile reflux in Barrett’s esophagus: a tale of two evils [editorial]. Gastroenterology 2001; 121: 1502–6.
   PubMed Web of Science ®Google Scholar
• Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett’s esophagus. Surgery 1994;117:699–704.
   Google Scholar
• Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192–9.
   PubMed Web of Science ®Google Scholar
• Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett’s esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929–34.
   PubMed Web of Science ®Google Scholar
• Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391–9.
   Google Scholar